Monoamine transporter and receptor interaction profiles of novel psychoactive substances: Para-halogenated amphetamines and pyrovalerone cathinones
@article{Rickli2015MonoamineTA, title={Monoamine transporter and receptor interaction profiles of novel psychoactive substances: Para-halogenated amphetamines and pyrovalerone cathinones}, author={Anna Rickli and Marius C. Hoener and Matthias E. Liechti}, journal={European Neuropsychopharmacology}, year={2015}, volume={25}, pages={365-376} }
139 Citations
Pharmacological profile of mephedrone analogs and related new psychoactive substances
- Biology, ChemistryNeuropharmacology
- 2018
Pharmacological profiling of novel psychoactive substances
- Biology, ChemistryNovel Psychoactive Substances
- 2022
Pharmacological characterization of 3,4-methylenedioxyamphetamine (MDA) analogs and two amphetamine-based compounds: N,α-DEPEA and DPIA
- Biology, ChemistryEuropean Neuropsychopharmacology
- 2022
Pharmacology of MDMA- and Amphetamine-Like New Psychoactive Substances.
- Biology, PsychologyHandbook of experimental pharmacology
- 2018
The conclusion is made that abuse liability for amphetamine-like NPS may be higher than for MDMA- like NPS, but that the risk for developing the life-threatening serotonin syndrome may be increased for ecstasy-likeNPS.
Receptor interaction profiles of novel psychoactive tryptamines compared with classic hallucinogens
- Biology, ChemistryEuropean Neuropsychopharmacology
- 2016
Monoamine Transporter and Receptor Interaction Profiles of Synthetic Cathinones
- Biology, Chemistry
- 2018
There are considerable differences among cathinones with respect to potencies and relative activity at monoaminergic targets, and in vitro screening and pharmacological classification are essential in providing translationally valuable information promptly after new cathinone derivatives emerge among drug users.
Structure-Activity Relationships of Substituted Cathinones, with Transporter Binding, Uptake, and Release
- Chemistry, BiologyThe Journal of Pharmacology and Experimental Therapeutics
- 2017
Interactions of 20 “bath salt” components with human dopamine, serotonin, and norepinephrine transporters heterologously expressed in human embryonic kidney 293 cells suggested thresholds of binding/uptake ratios above which compounds were likely to be substrates.
The synthetic cathinone psychostimulant α-PPP antagonizes serotonin 5-HT2A receptors: In vitro and in vivo evidence.
- BiologyDrug testing and analysis
- 2019
The results suggest α-PPP has antagonist interactions at 5-HT2A R in vitro that may translate at physiologically-relevant doses in vivo that may contribute to α- PPPs unpopularity compared to other monoamine transporter inhibitors.
Monoamine receptor interaction profiles of 4-aryl-substituted 2,5-dimethoxyphenethylamines (2C-BI derivatives).
- Chemistry, BiologyEuropean journal of pharmacology
- 2019
Metabolites of the ring-substituted stimulants MDMA, methylone and MDPV differentially affect human monoaminergic systems
- Biology, ChemistryJournal of psychopharmacology
- 2019
Several metabolites of MDMA, methylone and MDPV interact with human transporters and receptors at pharmacologically relevant concentrations and could contribute to the in vivo activity of the parent compounds in human users.
References
SHOWING 1-10 OF 50 REFERENCES
Monoamine transporter and receptor interaction profiles of a new series of designer cathinones
- Biology, ChemistryNeuropharmacology
- 2014
Substituted methcathinones differ in transporter and receptor interactions.
- Biology, ChemistryBiochemical pharmacology
- 2013
N-Desalkylquetiapine, a Potent Norepinephrine Reuptake Inhibitor and Partial 5-HT1A Agonist, as a Putative Mediator of Quetiapine's Antidepressant Activity
- Psychology, BiologyNeuropsychopharmacology
- 2008
The data strongly suggest that the antidepressant activity of quetiapine is mediated, at least in part, by its metabolite N-DesalkylquetiAPine through NET inhibition and partial 5-HT1A agonism.
Interaction of psychoactive tryptamines with biogenic amine transporters and serotonin receptor subtypes
- Biology, ChemistryPsychopharmacology
- 2014
All psychoactive tryptamines are 5-HT2A agonists, but5-HT transporter (SERT) activity may contribute significantly to the pharmacology of certain compounds, and in vitro transporter data confirm structure-activity trends for releasers and uptake inhibitors whereby releasers tend to be structurally smaller compounds.
Neurochemical profiles of some novel psychoactive substances.
- Chemistry, BiologyEuropean journal of pharmacology
- 2013
Powerful Cocaine-Like Actions of 3,4-Methylenedioxypyrovalerone (MDPV), a Principal Constituent of Psychoactive ‘Bath Salts’ Products
- BiologyNeuropsychopharmacology
- 2013
The data show that MDPV is a monoamine transporter blocker with increased potency and selectivity for catecholamines when compared with cocaine, and may provide a mechanism to explain the adverse effects observed in humans taking high doses of ‘bath salts’ preparations.
The Designer Methcathinone Analogs, Mephedrone and Methylone, are Substrates for Monoamine Transporters in Brain Tissue
- BiologyNeuropsychopharmacology
- 2012
In vitro and in vivo methods demonstrate that designer methcathinone analogs are substrates for monoamine transporters, with a profile of transmitter-releasing activity comparable to MDMA.
Pharmacological profile of antidepressants and related compounds at human monoamine transporters.
- Biology, PsychologyEuropean journal of pharmacology
- 1997
Pharmacological profiles of aminoindanes, piperazines, and pipradrol derivatives.
- Chemistry, BiologyBiochemical pharmacology
- 2014
Relationship between the Serotonergic Activity and Reinforcing Effects of a Series of Amphetamine Analogs
- BiologyJournal of Pharmacology and Experimental Therapeutics
- 2005
The results suggest that the mechanism for this effect involves a decrease in reinforcing potency and efficacy among monoamine releasing agents when 5-HT releasing potency is increased relative to DA.